Açık
Pozisyonlar
WHATSAPP
+908502224469
Op. Dr. Aylin Koç Akbay
Op. Dr.

Aylin Koç Akbay

Eye Diseases Specialist
Istanbul - Etiler
Faceți o programare

NATIONAL AND INTERNATIONAL PUBLICATIONS

Onal S, Kazokoglu H, Koc A, Yavuz S. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener’s Granulomatosis. Ocul Immunol Inflamm. 2008;16:230-2.

Onal S, Kazokoglu H, Koç A, Akman M, Bavbek T, Direskeneli H, Yavuz S. Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet’s uveitis. Clin Exp Rheumatol. 2009;27 (Suppl. 53):113-114.

Koc A, Onal S, Yenice O, Kazokoglu H. Pars plana vitrectomy and intravitreal liposomal amphotericin B in the treatment of candida endophthalmitis. Ophthalmic Surg Lasers Imaging. 2010 doi: 10.3928/15428877-20100215-35

Onal S, Kazokoglu H, Koç A, Akman M, Bavbek T, Direskeneli H, Yavuz S. Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis. Arch Ophthalmol. 2011;129:288-294.

Koc A, Onal S, Kazokoglu H, Tulunay A, Eksioglu Demiralp E, Direskeneli H, Yavuz S. Effect of interferon alfa-2a on peripheral blood CD4+CD25+ T regulatory cells in patients with Behçet uveitis: preliminary study. Int J Ophthalmol Clin Res 2015, 2:1-5. 

Koc A, Toker E. Kontakt Lense Bağlı Stenotrophomonas maltophilia Keratiti: Gatifloksasin ile Başarılı Tedavi. Turkiye Klinikleri J Ophthalmol 2010;19(1):63-7 

Savar F, Yenice O, Kazokoglu H, Koc A. Radyasyon Optik Nöropatisi. T Oft Gaz 2008;38:533-537. 

Kitap Bölümleri Çevirileri:

Koc A. Chapter 24, [Iris and ciliary body]. Section 11. Uveal tract. In: [Basic Eye Diseases], ed Aydın O’Dwyer P, Akova Y. 2nd edition. Gunes Medical Publisher. 2011: 417-424. ISBN:9789752773318

Onal S, Koc A. Chapter 45, [Treatment principles of Uveitis]. Section 11. Uveal tract. In: [Basic Eye Diseases], ed Aydın O’Dwyer P, Akova Y. 3nd edition. Gunes Medical Publisher. 2015: 545-560. ISBN:978975275923 

Eğitim Katlımları ve Sözlü&Yazılı Bildirimleri 

25. Ulusal Oftalmoloji Nisan Kursu Ankara, Nisan 01-03, 2005, Türkiye 

Uludağ 2005. Mezuniyet Sonrası Eğitim Programı. Oftalmoloji Günleri, Oftalmolojide Son Gelişmeler, Bursa, 03-05 Haziran, 2005; Türkiye 

Uludağ 2006. Mezuniyet Sonrası Eğitim Programı. Oftalmoloji Günleri, Katarakt Cerrahisi, Bursa, 29-30 Nisan, 2006; Türkiye 

Mediterranean Retina II, Antalya, Haziran 23-25, 2006, Türkiye 

New-threapies in Retinal Diseases, Rome, Eylül 07-08, 2006, İtalya 

6th International AMD Congress, Cenevre, Eylül 22-23, 2006, İsviçre 

Türk Oftalmoloji Derneği 40. Ulusal Oftalmoloji Kongresi, Antalya, Ekim 28- Kasım 01, 2006, Türkiye 

27. Ulusal Oftalmoloji Nisan Kursu Ankara, Nisan 06-08, 2007, Türkiye

8th European Neuro-Ophthalmology Society (EUNOS) Meeting, İstanbul,  Mayıs 26-29, 2007; Türkiye 

Joint Congress of European Ophthalmology Society and American Academy of Ophthalmology (SOE/AAO), Viyana, Haziran 9-12, 2007; Avusturya 

Türk Oftalmoloji Derneği 41. Ulusal Oftalmoloji Kongresi, Antalya, Ekim 30- Kasım 02, 2007, Türkiye 

Türk Oftalmoloji Derneği, 5. Mart Sempozyumu, Van, Mart 14-16, 2008; Türkiye 

28. Ulusal Oftalmoloji Nisan Kursu Ankara, Nisan 11-13, 2008, Türkiye 

Türk Oftalmoloji Derneği 42. Ulusal Oftalmoloji Kongresi, Antalya, Kasım 19-23, 2008, Türkiye 

Türk Oftalmoloji Derneği Kış Sempozyumu, Bursa, 23-25, 2009; Türkiye 

29. Ulusal Oftalmoloji Nisan Kursu Ankara, Nisan 10-12, 2009, Türkiye 

Academy for Eyecare Excellence, Cıba Vision, Kıbrıs, Mayıs 01-03, 2009, Türkiye 

Türk Oftalmoloji Derneği 22. Yaz Sempozyumu, İzmir, Haziran 26-28, 2009, Türkiye 

Türk Oftalmoloji Derneği 43. Ulusal Oftalmoloji Kongresi, Antalya, Kasım 11-15, 2009; Türkiye 

31. Ulusal Oftalmoloji Nisan Kursu Ankara, Nisan 01-03, 2011, Türkiye 

II. Kuru Göz ve Oküler YüzeyOlgu Sunumu, Antakya, 7 Mayıs, 2011; Türkiye 

Türk Oftalmoloji Derneği, 9. Mart Sempozyumu, Adana, Mart 16-18, 2012; Türkiye 

Türk Oftalmoloji Derneği 47. Ulusal Oftalmoloji Kongresi, Antalya, Kasım 06-10, 2013; Türkiye 

World Ophthalmology Congress (WOC) Of The International Council Of ophthalmology, Tokyo, Nisan 02- 06,2014, Japonya 

14th ESASO Retina Academy 2014, İstanbul, Kasım 13-15, 2014; Türkiye 

15th ESASO Retina Academy 2015, Barselona, Kasım 22-24, 2015; İspanya 

Türk Oftalmoloji Derneği 49. Ulusal Oftalmoloji Kongresi, İstanbul, Kasım 04-08, 2015; Türkiye.

Koc A, Bavbek T. Intravitreal triamcinolone and argon laser photocoagulation for treatment of juxtafoveal telengiectasis. Mediterranean Retina II, Antalya, June 23-25, 2006, TURKEY

Koc A, Bavbek T. Cyrptococcus neoformans chorioretinal lesions in a non-AIDS patient. Mediterranean Retina II, Antalya,  June 23-25, 2006, TURKEY

Koc A, Onal S, Kazokoglu H. Primary central nervous system lymphoma presenting as uveitis. 8th European Neuro-Ophthalmology Society (EUNOS) Meeting, Istanbul, May 26-29, 2007; TURKEY

Koc A, Onal S, Kazokoglu H. Ocular toxoplasmosis: clinical features and prognosis of 23 Turkish patients. Joint Congress of European Ophthalmology Society and American Academy of Ophthalmology (SOE/AAO), Vienna, June 9-12, 2007; AUSTRIA

Koc A, Onal S, Kazokoglu H. [Primary central nervous system lymphoma presenting as uveitis]Turkish Ophthalmology Society 41st National Congress on Ophthalmology, Antalya,  October 30-November 2, 2007; TURKEY

Onal S, Kazokoglu H, Koc A, Bavbek A, Direskeneli H, Yavuz S. Safety and efficacy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet’s uveitis: a prospective study of 16 cases.  The Second Meeting of the Society for Ophthalmo-Immunoinfectiology in Europe (SOIE). Cappadocia, June 12-15, 2008, TURKEY

Onal S, Kazokoglu H, Koc A, Bavbek A, Direskeneli H, Yavuz S. [Safety and efficacy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet’s uveitis: a prospective study of 16 cases].  Turkish Ophthalmology Society 42nd National Congress on Ophthalmology, Antalya, November 19-23, 2008; TURKEY

Onal S, Kazokoglu H, Koç A, Yavuz S. [Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener’s granulomatosis]. Turkish Ophthalmology Society 42nd National Congress on Ophthalmology, Antalya, November 19-23, 2008; TURKEY

Koc A, Onal S, Yenice O, Kazokoglu H. [Pars plana vitrectomy and intravitreal liposomal amphotericin B in the treatment of candida endophthalmitis]Turkish Ophthalmology Society 42nd National Congress on Ophthalmology, Antalya,  November 19-23, 2008; TURKEY

Onal S, Oray M, Kazokoglu H, Koc A, Direskeneli H, Yavuz S. Efficacy of low dose interferon alfa-2a in refractory and sight-threatening uveitis: A prospective study of six cases. The 17th Congress of the European Society of Ophthalmology, Amsterdam, June 13-16, 2009; THE NETHERLANDS

Koc A, Onal S, Kazokoglu H, Bavbek T, Direskeneli H, Yavuz S. Long-term efficacy of low-dose interferon alfa-2a treatment in refractory and sight-threatening Behçet’s uveitis. The 17th Congress of the European Society of Ophthalmology, Amsterdam, June 13-16, 2009; THE NETHERLANDS

Koc A, Toker E. Acase report; Treated with Homologous serum diagnosed with Riley-Day syndrom. The Turkish Ophthalmology Society 43rd National Congress on Ophthalmology, Antalya,  November 11-15, 2009; TURKEY

Onal S,  Kazokoglu H, Oray M, Koc A, Direskeneli H, Yavuz S. [Efficacy of low dose interferon alfa-2a in refractory and sight-threatening uveitis]. The Turkish Ophthalmology Society 43rd National Congress on Ophthalmology, Antalya,  November 11-15, 2009; TURKEY

Koc A, Onal S, Kazokoglu H, Bavbek T, Direskeneli H,Yavuz S. [Long-term efficacy of low-dose interferon alfa-2a treatment in refractory and sight-threatening Behçet’s uveitis]Turkish Ophthalmology Society 43rd National Congress on Ophthalmology, Antalya, November 11-15, 2009; TURKEY

Onal S, Koc A, Kazokoglu H, Bavbek T, Direskeneli H, Yavuz S. Long-term safety and efficacy of low dose interferon alfa-2a therapy in refractory and sight-threatening Behçet’s uveitis. National Behçet’s Disease Congress, Istanbul, December 18-20, 2009; TURKEY

Koc A, Onal S, Kazokoglu H, Tulunay A, Eksioglu Demiralp E, Direskeneli H, Yavuz S. Effect of interferon alfa-2a therapy on peripheral blood CD4+CD25+ T regulatory cells in patients with Behçet’s uveitis. 14th International Conference on Behçet’s Disease (ICBD), London, July 8-10, 2010; ENGLAND

Onal S, Kazokoglu H, Koc A, Akman M, Bavbek T, Direskeneli H, Yavuz S. Long-term efficacy and safety of low dose and dose escalating interferon alfa-2a therapy in refractory Behçet’s uveitis. 14th International Conference on Behçet’s Disease (ICBD), London, July 8-10, 2010; ENGLAND

Onal S, Koc A, Kazokoglu H, Tulunay A, Eksioglu Demiralp E, Direskeneli H, Yavuz S. Effect of interferon alfa-2a therapy on peripheral blood CD4+CD25+ T regulatory cells in patients with Behçet uveitis. The American Academy of Ophthalmology (AAO) and Middle East African Council of Ophthalmology (MEACO) Joint Meeting, Chicago, IL; October 16-19, 2010; USA

Onal S, Kazokoglu H, Koc A, Akman M, Bavbek T, Direskeneli H, Yavuz S. Long-term efficacy and safety of low dose and dose escalating interferon alfa-2a therapy in refractory Behçet uveitis. The American Academy of Ophthalmology (AAO) and Middle East African Council of Ophthalmology (MEACO) Joint Meeting, Chicago, IL; October 16-19, 2010; USA

Oray M, Onal S, Ashour A, Koc A, Ogut MS. Diverse clinical presentations of ocular cat scratch disease in a tertiary eye care center in Turkey. The 3rd World Congress on Controversies in Ophthalmology (COPHy), Istanbul, March 22-25, 2012; TURKEY

Koc A, Bavbek T. Frequent  Dexamethasone Implants in Macular Edema due to Retinitis Pigmentosa. 14th ESASO Retina Academy 2014, Istanbul, November 13-15, 2014; TURKEY

Onal S, Koc Akbay A, Uludag G. Interferon alpha-2a in the treatment of chronic and persistent cystoid macular edema in tuberculosis related retinal vasculitis. 13th Congress of International Ocular Inflammation Society (IOIS), San Francisco, California, September 25-27, 2015; USA 

Uludag G, Onal S, Koc Akbay A, Selcukbiricik F, Arf S, Mandel N.MElectroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy. 13th Congress of International Ocular Inflammation Society (IOIS), San Francisco, California, September 25-27, 2015; USA 

Uludag G, Koc Akbay A, Kasapcopur O, Onal S. Efficacy of conventional immunomodulatory therapy and biologic agents in non-infectious pediatric uveitis. 13th Congress of International Ocular Inflammation Society (IOIS), San Francisco, California, September 25-27, 2015; USA 

Koc Akbay A, Onal S, Uludag G. Interferon alpha-2a in the treatment of chronic and persistent cystoid macular edema in tuberculosis related retinal vasculitis. 15th ESASO Retina Academy 2015, Barcelona, October 22-24, 2015; SPAIN

Koc Akbay A, Onal S, Uludag G. Interferon alpha-2a in the treatment of chronic and persistent cystoid macular edema in tuberculosis related retinal vasculitis.The Turkish Ophthalmology Society 49th National Congress on Ophthalmology, Istanbul, November 4-8, 2015; TURKEY

Uludag G, Onal S, Koc Akbay A, Selcukbiricik F, Arf S, Mandel N.MElectroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy. The Turkish Ophthalmology Society 49th National Congress on Ophthalmology, Istanbul, November 4-8, 2015; TURKEY 

Uludag G, Koc Akbay A, Kasapcopur O, Onal S. Efficacy of conventional immunomodulatory therapy and biologic agents in non-infectious pediatric uveitis. The Turkish Ophthalmology Society 49th National Congress on Ophthalmology, Istanbul, November 4-8, 2015; TURKEY 

Koc Akbay A, Onal S, Yaşa Ç, Oray M, Uludag G, Akman M, Tugal-Tutkun I. Evaluation of vision and general health-related quality of life, depression and anxiety in patients with active uveitis. The Turkish Ophthalmology Society 49th National Congress on Ophthalmology, Istanbul, November 4-8, 2015; TURKEY

Folosim module cookie pentru a vă oferi cea mai bună experiență posibilă pe site-ul nostru. Prin continuarea navigării pe www.dunyagoz.com, sunteți de acord cu utilizarea acestora.

Aflați mai multe informații